LJI gives Leinco Tech exclusive access to SARSCoV- 2 antibodies against nucleocapsid protein
La Jolla Institute for Immunology (LJI), a leading research organization focussed on studying the immune system has signed a licensing agreement with Leinco Technologies, a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates. Leinco also provides custom manufacturing services to the diagnostic and biopharmaceutical industries to leverage proprietary COVID-19 antibodies developed at […]
